GUMDROP : NCI 11-C-0262 A Randomized, Double-blind, Phase 3 Efficacy Trial of PROSTVAC-V,F ± GM-CSF in Men with Asymptomatic or Minimally Symptomatic Metastatic, Castrate-Resistant Prostate Cancer

Created by Marte, Jenn (NIH/NCI) [E], last modified on Feb 27, 2012

Description:

A phase 3 study to determine whether PROSTVAC alone or in combination with GM-CSF is effective in prolonging overall survival in men with few or no symptoms from metastatic, castrate-resistant prostate cancer.

Link:

ClinicalTrials.gov

Site:

NCI

Principal Investigator:

James L. Gulley